Author:
Monk Bradley J.,Herzog Thomas J.,Wang George,Triantos Spyros,Maul Scott,Knoblauch Roland,McGowan Tracy,Shalaby Waleed S.W.,Coleman Robert L.
Funder
Janssen Research & Development
Subject
Obstetrics and Gynecology,Oncology
Reference30 articles.
1. Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer;Alvarez;Gynecol. Oncol.,2016
2. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Ann. Oncol.,2019
3. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ledermann;Ann. Oncol.,2016
4. Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action;Erba;Eur. J. Cancer,2001
5. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair;Takebayashi;Nat. Med.,2001
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献